DBT
ITCI

Dubuque Bank & Trust’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Dubuque Bank & Trust’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-250
Closed -$3K – 627
2019
Q1 		$3K Hold
250
– – ﹤0.01% 636
2018
Q4 		$3K Hold
250
– – ﹤0.01% 568
2018
Q3 		$5K Hold
250
– – ﹤0.01% 513
2018
Q2 		$4K Hold
250
– – ﹤0.01% 561
2018
Q1 		$5K Hold
250
– – ﹤0.01% 576
2017
Q4 		$4K Hold
250
– – ﹤0.01% 597
2017
Q3 		$4K Buy
+250
New +$3.67K ﹤0.01% 574
2016
Q3 		– Sell
-250
Closed -$10K – 599
2016
Q2 		$10K Buy
+250
New +$8.98K ﹤0.01% 430

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
SC
Samlyn Capital New York $5.82B AUM 36.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return